What adverse reactions may occur while taking selinesol?

A variety of adverse reactions may occur while taking selinesol.

1.Hematological side effects: Selinisol may cause bone marrow suppression, manifested by reduced hemoglobin, thrombocytopenia and leukopenia. These side effects may affect the patient's hematopoietic function and immunity, and increase the risk of infection and bleeding. Therefore, blood routine indicators need to be closely monitored during medication.

2.Digestive system side effects: Patients may experience digestive system adverse reactions such as nausea, vomiting, constipation and diarrhea. These reactions may affect the patient's appetite and nutrient absorption, leading to weight loss and electrolyte imbalance. Patients are advised to keep a light diet and avoid irritating foods during medication.

3. Respiratory side effects: Some patients may experience symptoms such as shortness of breath and chest tightness when taking the drug. These symptoms may affect the patient's respiratory function and quality of daily life. For patients with severe respiratory symptoms, they should seek medical treatment promptly and take appropriate treatment measures.

4.Systemic side effects: Long-term use of selinesol may cause symptoms such as general fatigue, weight loss, and fever. These symptoms may be related to the long-term effects of the drug, and patients need to pay attention to rest and nutritional supplements during the medication.

5.Allergic reaction: Some patients are allergic to selinesol and may experience allergic reactions such as rash and skin itching. In severe cases, it can even lead to life-threatening symptoms such as laryngeal edema and difficulty breathing. Therefore, before using selinesol, patients should inform their doctor of their allergic history so that the doctor can assess the risks of taking the drug.

6.Visual abnormalities: Seleniso may also cause visual abnormalities, such as blurred vision, abnormal color vision, etc. This may be related to the drug's effect on neurotransmitters, which may even lead to temporary blindness in severe cases. Therefore, it is recommended that patients regularly monitor changes in vision and eye health during medication.